HDTenEightyP/NetNews huggingface dataset:
From: des@helix.nih.gov (David E. Scheim)
Subject: Re: wisdom teeth removal
Organization: NIH
Date: Wed, 2 Sep 1992 14:07:57 GMT

In article <KPC.92Sep1172935@zog.arc.nasa.gov> kpc@pluto.arc.nasa.gov (k p c) writes:

>does anybody have any wisdom to offer to a 27 year old who has to have
>all 4 wisdom teeth removed?

>ideas, comments, warnings or bay area oral surgeon
>recommendations/disrecommendations would be great.

>(it's actually a suggestion, by a dentist who noticed 3 cavities, to
>have all 4 teeth removed by an oral surgeon.)
>--
>i'm open to comparing research career notes with other young cogsci people.
>-- 
>i'm open to comparing research career notes with other young cogsci people.

I was told by several dentists in my 20s, 20 years ago, to have my wisdom 
teeth removed.  I ignored them and my teeth have been fine all these years.  
I'm sure there are times when it's a good idea to preempt later problems by 
removing wisdom teeth but I suspect some dentists are a bit overzealous and 
may create problems where none exist.

/*********************************************************************/
/*                      --- David E. Scheim ---                      */
/* BITNET: DES@NIHNEI31                                              */
/* INTERNET: desl@helix.nih.gov          PHONE: 301 496-2194         */
/* CompuServe: 73750,3305                  FAX: 301 402-1065         */
/*                                                                   */
/* DISCLAIMER: These comments are offered to share knowledge based   */
/*   upon my personal views.  They do not represent the positions    */
/*   of my employer.                                                 */
/*********************************************************************/
From: summers%asylum.cs.utah.edu@cs.utah.edu (Jim Summers)
Newsgroups: sci.med
Subject: Re: Infra-red Glucose Meters
Date: 31 Aug 92 17:18:10 GMT
Organization: University of Utah CS Dept

In article <1992Aug30.054156.29290@wolves.uucp> wolfe@wolves.uucp (G. Wolfe Woodbury) writes:
>In article <1992Aug25.152853.25020@lonex.rl.af.mil> claudia@lonex.rl.af.mil (Claudia M. Servadio-Coyne) writes:
>>
>>Has anyone in the diabetic community heard any status at all on the
>>new infra-red glucose meters?  what company is making them?
>>Where FDA stands on approval? Is there any other place to get information
>>on this?
>
>I believe that the new "One Touch" meter from Johnson&Johnson is an IR
>based meter.  It's been available for a few months now, and I saw it in
>use at Duke in a research/testing situation about a year ago. (In the
>clinic, they asked patients coming thru if they could get an additional
>bit of blood from the "finger stick" to do a comparison test on the
>"new" machine - we agreed *after* asking if there were an extra charge
>for the additional test!  But that's another flame :-)
>
>My wife has been using the Ames Glucometer II for a while, and it
>started giving some odd results so we got the One Touch and keep the
>Ames as a back up.
>
>The One Touch is a cute little device, it has *two* micro laser LEDs and
>detector pairs.  One is visible, and I think the other is the IR pair.
>The real cute thing is that the One Touch has quite a bit of memory for
>keeping the readings, and can be hooked to a computer if you have the
>interest.  Its about time really modern computer technology was so
>affordable in such a small package.
>G. Wolfe Woodbury @ The Wolves Den UNIX, Durham NC         [use the maps!]

I agree with Mr. Wolfe on this.  I use the One Touch II and have
been very pleased with it.  Memory and average reading are all very
nice. 

However, I think the question was about "strip-less" meters -- put
blood on a lens and get a direct reading,  without having to put blood
on a strip first.  I have heard of testing of these in ?Canada?, but
have not facts at all.  I think a big bottleneck is that they will not
offer the profits that using strips do: assuming you test 3 times/day
with the One Touch II, you are shelling out for 150 strips/week, at
over $35/100 strips.  A direct infrared sensor that doesn't need a
strip would allow unlimited testings, and this would be reflected in
the price of the meter -- I would expect them to be at least $1000.

Anyone have any data on this?  Did I reinterpret the question
correctly?

LostBoy
jim
From: levin@bbn.com (Joel B Levin)
Newsgroups: sci.med
Subject: Re: Do "deodorant rocks" contain aluminum?
Date: 3 Sep 92 17:28:54 GMT
Distribution: na
NNTP-Posting-Host: bbn.com

geb@dsl.pitt.edu (gordon e. banks) writes:

|No, you only get Alzheimer's if you drink soda pop from Aluminum
|cans or cook with aluminum cookware.  :-)

Oh oh.
From: lsnow@ncrclm.ClemsonSC.NCR.COM (Linda Snow)
Newsgroups: sci.med
Subject: Re: Chronic Vaginitis in 5 year old?
Date: 28 Aug 92 17:00:06 GMT
Reply-To: lsnow@ncrclm.ClemsonSC.NCR.COM (Linda Snow)
Organization: NCR E&M CLEMSON Liberty, SC

I assume you've checked for bath soap and/or bubble bath as the culprit?
From: Maurice.Broverman@f210.n163.z1.fidonet.org (Maurice Broverman)
Newsgroups: sci.med
Subject: Beta Carotene used in treatment of stomach cancer
Date: 26 Aug 92 13:35:35 GMT
Organization: FidoNet node 1:163/210 - Ned's Opus, Ottawa ON

Can anyone advise of studies indicating the efficacy of using massive doses of 
beta carotene in the treatment of stomach cancer? Additionally, has a negative 
correlation been found between its usage in massive doses and the incidence of 
stomach cancer?



 

--  
Internet: Maurice.Broverman@f210.n163.z1.fidonet.org
Newsgroups: sci.med
From: cash@convex.com (Peter Cash)
Subject: Re: spina bifida information needed, please!
Date: Sat, 29 Aug 1992 18:53:17 GMT
Organization: The Instrumentality
X-Disclaimer: This message was written by a user at CONVEX Computer
              Corp. The opinions expressed are those of the user and
              not necessarily those of CONVEX.

In article <16208@pitt.UUCP> geb@dsl.pitt.edu (gordon e. banks) writes:
>In article <1992Aug24.055121.5009@news.eng.convex.com> cash@convex.com (Peter Cash) writes:

>Peter, you reacted very emotionally to my post and clearly missed
>that I said a positive outcome was possible.  

Yes, I did. In this medium, one confronts a very narrow slice of someone
else's thinking--as expressed in an article--with one's entire set of
emotional and cognitive baggage. Because the normal social restraints of
direct conversation aren't present, it's easy to put things more strongly
than one should.

I apologize for calling you ignorant, Gordon. You aren't. I am glad that I
prompted you to clarify your position on this matter.
-- 
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
             |      Die Welt ist alles, was Zerfall ist.     |
Peter Cash   |       (apologies to Ludwig Wittgenstein)      |cash@convex.com
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
From: geb@dsl.pitt.edu (gordon e. banks)
Newsgroups: sci.med
Subject: Re: Reaction to MMR Vaccine
Date: 31 Aug 92 15:06:31 GMT
Organization: Decision Systems Laboratory, Univ. of Pittsburgh, PA.

In article <1992Aug28.192733.2100@cbnewse.cb.att.com> elonich@cbnewse.cb.att.com (diane.e.pedersen) writes:
>
>My friend took her son for his pre-fifth grade physical,
>which included an MMR booster.
>
>While she was paying the bill, the boy suddenly turned
>white and felt dizzy and nauseous.
>

A vaso-vagal reaction (the most common reaction to a needle stick)
sounds like this.

>The nurse has him lie down awhile, and after a while
>he was released, where he went home and took an out-of-character
>2-hour nap.  The next day, he ran a mild fever.  He is fine now.
>

Fevers after shots are very, very common.

>The really wierd thing is that the  nurse mentioned that
>the boy's reaction was "the third time that has happened
>here this morning"
>

Maybe she's using too large gauge needles.






-- 
----------------------------------------------------------------------------
Gordon Banks  N3JXP      | "Skepticism is the chastity of the intellect, and
geb@cadre.dsl.pitt.edu   |  it is shameful to surrender it too soon." 
----------------------------------------------------------------------------
Newsgroups: sci.med
From: 880506s@dragon.acadiau.ca (James R. Skinner)
Subject: RIMA
Organization: Acadia University
Date: Wed, 26 Aug 1992 02:01:15 GMT


 	In the past my doctor has had me on a number of antidepressants 
including the SRI's Prozac, Luvox, and Zolft with Desyrel (not an SRI) being 
the most recent.  The SRI's worked quite well to lift the depression but the 
severty of the side effects ( insomina and anxiety )

	Recently my doctor has been discussing the idea of trying me on
the new class of antidepressants Reversible Inhibitors of Monoamine-oxidase A.
or simple RIMAs.  Since these are very new ( and supposedly don't have many
of the side effects older MOAs had ) I was wondering if anyone has taken 
this drug or knows any more information about them.
 

-- 

-----------------------------------+--------------------------------------------
        James Robie Skinner        |     Jodrey School of Computer Science        James.Skinner@dragon.acadiau.ca  |  Acadia University, Wolfville, NS, Canada
-----------------------------------+--------------------------------------------
From: bechtler@asdg.enet.dec.com (Laurie Bechtler)
Newsgroups: sci.med
Subject: Nizoral for toenail fungus
Date: 31 Aug 92 17:57:26 GMT
Organization: Digital Equipment Corporation



I've just started taking Nizoral, and was planning to the library and
find some information on it.  At the same time, I wanted to look up
the other commonly prescribed oral medication for fungi.  At least,
my doctor only mentioned two.  The problem is that I didn't write down
the name of the second one and promptly forgot it (those catchy drug 
names, many sound alike).  Does anyone know what I'm talking about?

And I can't tell you how well the Nizoral works because I've only
taken it for 4 days.  But my doctor wants to do a blood chemistry once
a month because of "rare" side effects to the liver, which makes me
want to read the list for myself.  Still, my desire to treat my bad
case of fungus overrides most concerns about rare side effects.

Thanks,
Laurie
From: bruno@hpfcso.FC.HP.COM (Bruno Melli)
Date: Tue, 1 Sep 1992 16:14:20 GMT
Subject: Re: tele # of the foundation for IBD related issues
Organization: Hewlett-Packard, Fort Collins, CO, USA
Newsgroups: sci.med

> Could you post the name of the foundation
> and the telephone number please?

Crohn's and Colitis Foundation of America (formerly the National Foundation
for Ileitis and Colitis).
If you are not in NY you need to call the 800 number.

greater NY:
  (212) 679-1570

Nat. Headquarters:
  (212) 685-3440

Nat.
  800 932 2423

Newsgroups: sci.med
From: u734120@bruny.cc.utas.edu.au (John Lamp)
Subject: Re: Vegemite (Was B12)
Organization: University of Tasmania, Australia.
Date: Wed, 26 Aug 1992 03:34:41 GMT

bhjelle@carina.unm.edu () writes:

>Is that who makes the famed Vegemite? Kraft? That explains a lot.
>The creators of Cheeze Whiz and Velveeta seem to have cornered
>the market on such products, except for Vienna sausages and
>Spam.

Actually Vegemite was devised by an Australian company during
the 1930's depression as a low cost nutritious spread. Kraft entered
the scene much later and bought out the company.

Cheers
John


--
   _--_|\             John Lamp, originating in Hobart, Tasmania
  /      \                 Phone: 002 23 1366 - Fax: 002 34 5685
  \_.--._/                   email: u734120@bruny.cc.utas.edu.au
        v <-----------------------------------------------------
Newsgroups: sci.med
From: mdkline@rodan.acs.syr.edu (Mark D. Kline)
Subject: Re: How does Ritalin work?
Organization: Syracuse University, Syracuse, NY
Date: Wed, 2 Sep 92 19:57:37 EDT

In article <1992Sep1.140805.1353@chpc.utexas.edu> jbyrd@chpc.utexas.edu (Jan Byrd) writes:
>My 8-year-old son has just started on Ritalin for Attention Deficit
>Disorder, and it has made a miraculous difference in his ability to
>focus on his classwork, pay attention, listen to and understand in-
>structions, complete work, etc.   Before this, even staying seated
>for the duration of a class period was too much for him.
>
>I'm wondering now if anyone can explain to me, a layperson, how 
>Ritalin works... 

Ritalin (methylphenidate - Ciba Geigy) is a mild psychostimulant
medication that increases the release of the neurotransmitters dopamine
and norepinephrine in the brain.  The basic hypothesis that tries to
explain how this kind of medication is helpful suggests that children
with attention-deficit disorder (ADD) or attention-deficit
hyperactivity disorder (ADHD) may have deficient native activity in
ascending activating pathways in the brain, which run from brain stem
nucleii to the cerebral cortex, the "higher centers." Such ascending
pathways in the brain regulate the level of arousal; the theory is that
ADD kids are underaroused, and their hyperactivity or deficient focus
are a sign of or attempt to compensate for the decreased level of
central nervous system arousal.  This is meant to explain the seemingly
paradoxical "calming" effect of such drugs.  However, the effects of
the drugs are not actually "paradoxical" in the sense that
psychostimulants can increase the ability to sustain focus and
concentration in normal adults as well.

Ritalin is an abusable substance (it can cause euphoria, although less
than amphetamines) and can cause psychosis in extremely high doses
and depression when abusively high doses are stopped.  It is a 
controlled substance which requires a special triplicate prescription
form in many states.   Chronic abuse of Ritalin can result in the
development of tolerance. 

For most kids with ADD/ADHD, optimal outcome involves other treatment 
interventions in addition to medications -- depending on the child,
educational, family, or psychotherapy or other treatments may be helpful.

--
================================================================= 
mark kline                              mdkline@rodan.acs.syr.edu
suny health science center, syracuse    voice: (315) 422-1050
================ courtesy of syracuse university ================
Newsgroups: sci.med
Subject: FAQ-straw poll: results
From: RGINZBERG@eagle.wesleyan.edu (Ruth Ginzberg)
Date: 31 Aug 92 19:47:48 EDT
Distribution: world
Organization: Philosophy Dept., Wesleyan University
X-News-Reader: VMS NEWS 1.20Lines: 37

Results of FAQ straw poll so far:27-yes; 1-no.So I'm going to go ahead w. it.

A number of folks indicated interest and/or willingness re. *HELPING* w. the
creation of a(n) FAQ file; help *GLADLY* accepted.(see below)

Especially seeking folks w. MDs or other relevant formal education, & folks
from countries other than the U.S. to participate in creation of FAQ file(s). 
(desire: to minimize scientific inaccuracy & USA-centrism)

I'm going to create an off-net mailing list of those who want to participate in
the initial creation of the sci.med FAQ file(s).  That way we won't clutter the
newsgroup with bureaucratic details, intermediate results, preliminary
drafts, or communications with one another re. work-in-progress.  

One more time:  please e-mail me if you wish to *volunteer* to be part
of a sci.med FAQ file-creation working-group. {This could include formulation 
of a statement re. focus of this newsgroup; liability-limiting disclaimer(s);
suggested bibliograph[y/ies] and/or recommended readings; "fact files" re. 
commonly asked questions (e.g., carpal tunnel syndrome, CFS/CFIDS,
obesity, depression & anti-depressants, headache, allergies, GI complaints,
"smart drugs", homeopathy, how to get into med school, etc., etc., etc.); 
existence of, & uses of non-net resources [U.S. fda on-line info, Medline, 
PDR, DSM-III, package inserts from pharmacist, research grant info, (etc.)] 
for one's own research and/or self-education, etc.} Please include statement of
what you want to volunteer to work on, & what yr. background/interest is in
that area.

Future communication re.R&D on the FAQ file(s) will be off-net; completed FAQ 
file(s) will be posted when the working-group(s) have finished creating 
the file(s).

Nothing previously posted to sci.med will be used as a FAQ file entry without
the poster's explicit permission to include it in the sci.med FAQ file.

------------------------
Ruth Ginzberg <rginzberg@eagle.wesleyan.edu>
Philosophy Department;Wesleyan University;USA
Newsgroups: sci.med
From: cpr4k@holmes.acc.Virginia.EDU (Christian P. Roberts)
Subject: Re: Therapy and Psychiatry  (was: Anti-psychiatry)
Reply-To: cpr4k@holmes.acc.Virginia.EDU (Christian P. Roberts)
Organization: Academic Computing Center - U.Va.
Date: Fri, 4 Sep 1992 14:28:40 GMT

In article <18623tINNpj9@agate.berkeley.edu>, John Werner
<werner@soe.berkeley.edu> writes:
|> 
|> In article <16318@pitt.UUCP> gordon e. banks, geb@dsl.pitt.edu
|> writes:
|> >Not the future of psychiatry, the present.  Most psychiatrists are
|> >now biologically oriented and drug prescribers.  Especially
|> >the young ones.  Psychoanalysis is practically dead except among
the
|> >elderly psychiatrists.  It is a very inefficient way of doing
|> >psychotherapy anyway.
|>     . . .
|> My naive impression was that treatment was still mostly therapy,
|> with drugs prescribed as well (sometimes as a temporary measure,
|> sometimes long-term) when the psychiatrist thinks they will help. 
|> Is it now starting to be the other way around?
|> 
|> (I don't mean for this to sound "anti-psychiatric" or judgemental. 
|> Whatever works is fine with me.  In my particular case I decided
|> that there are enough underlying causes for my problems that therapy
|> was what I needed.  I can function pretty well in everyday life, so
|> it seemed like drugs would be overkill.)  
|> 
It's unfortunate that psychiatry seems to be turning in the direction
of drugs, as a first mode of treatment.  There is a genuine place for 
psychoanalytic psychotherapy, as John has indicated above.  We could 
get into a debate over whether drugs mask the symptoms, etc., but I 
don't think that is the point here.
It has been my experience that there are conditions which are best
handled with the 'working-through' approach of psychoanalysis.
Unfortunately, many health insurance companies are not cognizant
of its value.
I thank you for the information you provide over the net, Gordon.
I want to say, however, that efficiency is not the only thing to
consider in psychotherapy.  What works and assists the person in
finding a wholeness in a real world and healthy self-esteem which
lasts beyond therapy - this is what's important to those of us in
therapy.  What works for one may not work for another.  Drugs may
seem to provide quicker results, but the results may not be lasting.
John and I seem to agree that therapy may be the means to a health
for some of us.  Drug therapy helped me through a very anxiety-ridden
period, but then I needed to attend to the causes, and that is where
psychoanalysis has provided the tools.

--

Chris Roberts                     Academic Computing Center
cpr4k@virginia.edu                University of Virginia           
(804) 982-4693                    Charlottesville, Virginia 22903
From: geb@dsl.pitt.edu (gordon e. banks)
Newsgroups: sci.med
Subject: Re: moderate sci.med??? alternative suggestion
Date: 27 Aug 92 21:14:25 GMT
Organization: Decision Systems Laboratory, Univ. of Pittsburgh, PA.

In article <1992Aug25.173236.203@news.wesleyan.edu> RGINZBERG@eagle.wesleyan.edu (Ruth Ginzberg) writes:
>Other things that I thought might help:
>1)Keep a FAQ file, & get folks w. repititious questions to read the file rather
>than re-asking the question for the umpteenth time.

Excellent idea.  

>2)Take some of the educational function of sci.med to alt.uu (usenet
>university), where maybe some of the more highly educated folks from sci.med
>might be able to offer lay-folks' courses in medical science topics.  [I
>suspect there might be a fair amount of interest...]
>
I don't think I have time to do this.  I spend far too much time
on the net as it is.

>If enough folks think anything like the above could/would be helpful, I'd be
>happy to offer some amount of my humble service to implementing these (or
>other) organizational/administrative details.  I don't have an MD, but I do

Fine with me.


-- 
----------------------------------------------------------------------------
Gordon Banks  N3JXP      | "Skepticism is the chastity of the intellect, and
geb@cadre.dsl.pitt.edu   |  it is shameful to surrender it too soon." 
----------------------------------------------------------------------------
From: nigel.allen@canrem.com (Nigel Allen)
Newsgroups: sci.med
Subject: unc health care study
Date: 1 Sep 1992 21:18:06 -0500
Organization: UTexas Mail-to-News Gateway
NNTP-Posting-Host: cs.utexas.edu


Here is a press release from the Clinton/Gore Campaign.
 
 Clinton Campaign Statement on University of North Carolina Health
Care Study
 To: National Desk, Political Writer
 Contact: Avis LaVelle of the Clinton/Gore Campaign, 501-399-3840

   LITTLE ROCK, Ark., Aug. 31 /U.S. Newswire/ -- Statement of George
Stephanopoulos, Clinton/Gore communications director, on a health
care study released by University of North Carolina:

   "This study has one simple conclusion: Bill Clinton's health plan
would control costs and create 2.2 million more jobs than George
Bush's approach.
   "Bill Clinton supports comprehensive health care reform that
controls costs; George Bush wants to protect the insurance companies
and stick the elderly with the bill.  George Bush's hatchet plan for
Medicare benefits and do-nothing cost control scheme would increase
costs for families, but protect profits for insurance and
pharmaceutical companies.  The study released today shows just how
costly the Bush approach is.
   "What would happen under George Bush's assault on Medicare and
Medicaid?  According to the University of North Carolina study, the
Bush Plan would result in:
   -- 2.2 million jobs lost as health care costs continue to spiral
      out of control;
   -- Health costs consuming 12 percent of the income of elderly
      Americans by 1997; and
   -- 60 million uninsured Americans by 1997.
   "We need comprehensive reform, not piecemeal cuts.  The Clinton
Health Care Plan offers an approach that will control costs
throughout the health system and increase access and affordability.
  The Bush scheme will cost jobs; comprehensive reform will create
them, as health costs get under control to the benefit of workers and
businesses alike."
    ------
   NOTE: The study was conducted by Dr. Kenneth E. Thorpe, associate
professor of health policy and administration at the University of
North Carolina-Chapel Hill, School of Public Health.  For copies of
the study contact UNC News Services at 919-962-2091.  Thorpe is
available today for interviews.  Call him at 919-966-7375 (work) or
919-408-0168 (home).
   Thorpe, who has testified before congressional committees about
several national health-care proposals, specializes in national
health insurance, financing health care and other public and private
health care cost issues.
 -30-
--
Canada Remote Systems  - Toronto, Ontario/Detroit, MI
World's Largest PCBOARD System - 416-629-7000/629-7044
Newsgroups: sci.med